2011-12-01T15:17:09-05:00 2011-03-31 ERNST & YOUNG US LLP 1901 SIXTH AVE NORTH STE 1200 BIRMINGHAM AL 35203 990 2010-04-01 751835298 SUSAN G KOMEN BREAST CANCER FOUNDATION INC SUSA 9728551600 5005 LBJ FREEWAY DALLAS TX 752446125 MARK NADOLNY 2011-12-01 2052541608 2010 2016-02-24 21:20:13Z SUSAN G KOMEN FOR THE CURE Ambassador Nancy G Brinker 5005 LBJ FREEWAY STE 250 DALLAS TX 752446125 258876878 false 7164 X www.komen.org X 1982 TX Our mission is a world without breast cancer; to save lives by empowering people, ensuring quality care for all, and energizing science to discover and deliver the cures. 9 7 280 11823 0 0 134999587 174658160 32672067 34417471 2399901 6372156 1115204 -6491760 171186759 208956027 74580417 76205302 0 0 22675770 24232513 654519 829211 22288157 79677466 91171573 177588172 192438599 -6401413 16517428 298673925 319777847 212403483 205749113 86270442 114028734 X OUR MISSION IS A WORLD WITHOUT BREAST CANCER; TO SAVE LIVES BY EMPOWERING PEOPLE, ENSURING QUALITY CARE FOR ALL, AND ENERGIZING SCIENCE TO DISCOVER AND DELIVER THE CURES. false false 75926099 63897763 34417471 GRANTS TO OTHER CHARITABLE ORGANIZATIONS TO SUPPORT RESEARCH AND clinical investigation of breast cancer. See schedule O for additional details. 71129117 5068306 456632 PUBLIC HEATLH EDUCATION PROGRAMS TO INCREASE THE PUBLIC'S AWARENESS of breast cancer including, among other things, detection and treatment. See schedule O for additional details. 9142812 7239233 344476 HEALTH TREATMENT AND SCREENING PROGRAMS AND GRANTS. SEE SCHEDULE O for additional details. 156198028 true true false true false false false false true true false false false false true false true false false true true false true true false false true false true false false false false false false false false true false false false false false false false false false true 170 0 true 280 true false true IS false false false true true false false false false X 9 7 true false false false false false false true true false true true true true true true true true true true false AL AK AZ AR CA CO CT DC FL GA HI IL IN KS KY ME MD MA MI MN MS MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X X Mark Nadolny 9728551600 5005 LBJ FREEWAY SUITE 250 DALLAS TX 752446125 Alexine Clement Jackson 1.0 X 0 0 0 Eric Brinker 1.0 X 0 0 0 Linda Custard 1.0 X 0 0 0 Brenda Lauderback 1.0 X 0 0 0 Linda Law 1.0 X X 0 0 0 Connie O'Neill 1.0 X X 0 0 0 Dorothy Patterson 1.0 X 0 0 0 John D Raffaelli 1.0 X 0 0 0 Robert Taylor 1.0 X 0 0 0 Nancy G Brinker 55.0 X X 417171 0 541 Elizabeth Thompson 55.0 X 216920 0 16177 Katrina McGhee 55.0 X 216393 0 12204 Mark Nadolny 55.0 X 277636 0 17280 Jonathan Blum 55.0 X 210269 0 22124 Justin Ricketts 55.0 X 209541 0 17213 Emily Callahan 55.0 X 153490 0 8978 Jennifer Luray 1.0 X 0 0 0 Marianna Alciati 55.0 X 193571 0 14660 Nancy MacGregor 55.0 X 153341 0 16124 Diana Rowden 55.0 X 168171 0 11988 Susan Carter-Johns 55.0 X 165006 0 20137 Eric Winer 20.0 X 177897 0 0 Julie C Teer 55.0 X 198737 0 0 Mona L Locke 55.0 X 167373 0 2233 David A Dawson 55.0 X 163165 0 15346 Lesley Lurie 55.0 X 160184 0 12811 Samuel Cheng 55.0 X 159129 0 9156 Hala Moddelmog 0.0 X 277864 0 1870 Kimberly Earle 0.0 X 269609 0 2172 Annetta Hewko 0.0 X 134483 0 0 4089950 0 201014 50 true true false EVENT 360 INC 205 N MICHIGAN AVE CHICAGO IL 606015927 Event management 12256871 CONVIO INC 11921 N MOPAC EXPWY AUSTIN TX 752671445 Donation processing 3782356 CONSTELLA GROUP LLC 2605 MERIDIAN PARKWAY HAGERSTOWN NC 27713 Health consult. svc. 3634249 MERKLE INC 100 JAMISON COURT SAN FRANCISCO MD 21740 Donat. Process & Mkt 3039994 RADARWORKS 6100 WILSHIRE BLVD LOS ANGELES CA 90048 MARKETING 2461302 49 547774 85188640 88921746 48166 174658160 Affiliate payments 900099 34417471 34417471 34417471 3161593 3161593 0 650490 650490 38626959 35416396 3210563 3210563 3210563 5676828 85188640 13704224 -8027396 -8027396 0 801339 800231 1108 1108 Support services 900099 800000 800000 Other 900099 84038 84038 884038 208956027 35218579 0 -920712 72110320 72110320 0 4094982 4094982 0 2716831 2200633 190178 326020 0 17127226 10920912 4547456 1658858 811459 527230 208957 75272 2242130 1455213 572823 214094 1334867 871051 326420 137396 0 285983 192494 65692 27797 814308 541874 189746 82688 2500 2500 829211 829211 215530 215530 0 20105178 15168035 586841 4350302 14747106 8208683 484495 6053928 6296259 5130508 425280 740471 0 2065550 1386605 447953 230992 3264725 2255049 688249 321427 0 2457562 1698553 554045 204964 0 0 1607704 1095896 302796 209012 142258 72389 40004 29865 CONSULTING AND PROF SERVICES 14187337 12533270 702685 951382 EQUIP RENTAL AND MAINTENANCE 1054544 300249 498003 256292 Contract labor 7088737 5079832 612591 1396314 Event production 7313030 5581292 1483663 248075 Bank fees 3915225 640950 98940 3175335 5608037 4129508 710067 768462 192438599 156198028 13952414 22288157 X 38052478 12459846 3485309 22107323 116301040 50614983 63110996 59432769 3227334 1923864 2746321 3861903 613072 638001 4052357 2039706 13810342 10109328 4766127 3701014 103856678 197565607 298673925 319777847 27391172 32386936 185012311 173362177 212403483 205749113 X 37346956 66987655 48698486 46816079 225000 225000 86270442 114028734 298673925 319777847 X 16517428 11240864 X false true true X false X 125004591 132775607 127995868 134999587 174658160 695433813 0 0 0 0 0 0 0 0 0 0 0 0 125004591 132775607 127995868 134999587 174658160 695433813 15412732 680021081 6627304 8682291 6957976 3548746 3812083 29628400 0 0 0 0 0 0 50758 81914 71369 2589864 84038 2877943 727940156 189269260 0.93417 0.92399 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 0 439745 2500 112556 2500 552301 178483685 349711846 178486185 350264147 1000000 1000000 250000 250000 0 189745 0 0 true 1000000 1000000 1000000 1000000 4000000 6000000 1082050 375201 295135 552301 2304687 250000 250000 250000 250000 1000000 1500000 366511 275601 219954 439745 1301811 Lobbying Expenses PUBLIC POLICY INITIATIVES HAVE THE POTENTIAL TO IMPACT PEOPLE TOUCHED BY BREAST CANCER. RECOGNIZING THE POWER OF ADVOCACY TO ACCOMPLISH ITS MISSION, KOMEN SUPPORTS LIMITED LOBBYING ACTIVITIES TO ACHIEVE EVIDENCE-BASED POLICY AND LEGISLATIVE SOLUTIONS DESIGNED TO ELIMINATE BREAST CANCER AS A MAJOR HEALTH PROBLEM. 1318978 608 1319586 1323262 -4284 1318978 1318022 5240 1323262 0.76000 0.24000 0.00000 false false 795974 481829 314145 4416005 3867717 548288 8598363 5759782 2838581 3701014 0 0 Endowments Schedule D, Part V Two permanent endowments, Goodman-Brinker and Firnberg. Goodman-Brinker Endowment to be used for Breast Cancer Research fellowships. Firnberg Endowment to be used for breast cancer educational programs and research awards. FIN 48 (ASC740) Financial Statement Disclosure Schedule D, Part X, Line 2 THE ORGANIZATION IS SUBJECT TO A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THERE WERE NO UNCERTAIN TAX POSITIONS IN THE FINANCIAL STATEMENTS AT MARCH 31, 2011 OR MARCH 31, 2010. true Central America and the Caribbean 0 0 Grantmaking 184459 East Asia and the Pacific 0 0 Grantmaking 865265 Europe (Including Iceland and Greenland) 0 0 Grantmaking 1087000 Middle East and North Africa 0 0 Grantmaking 581000 North America 0 0 Grantmaking 860000 Russia and the Newly Independent States 0 0 Grantmaking 22258 South America 0 0 Grantmaking 375000 Sub-Saharan Africa 0 0 Grantmaking 120000 Middle East and North Africa 0 22 Program Services EDUC. & EVENT SUPPORT 414272 Central America and the Caribbean 0 10 Program Services EDUC. & EVENT SUPPORT 77412 Europe (Including Iceland and Greenland) 0 3 Program Services EDUC. & EVENT SUPPORT 144965 South America 0 0 Program Services EDUCATION 14381 0 35 0 35 4746012 4746012 Sub-Saharan Africa Education 50000 wire transf Middle East/North Africa Education 100000 wire transf Europe/Iceland/Greenland Research 250000 wire transf Europe/Iceland/Greenland Education 28000 wire transf Middle East/North Africa Education 41000 wire transf Sub-Saharan Africa Education 35000 wire transf North America Research 250000 wire transf Cent. America/Caribbean Education 25000 wire transf Middle East/North Africa Research 250000 wire transf Europe/Iceland/Greenland Education 25000 wire transf Europe/Iceland/Greenland Education 25000 wire transf South America Education 100000 wire transf Europe/Iceland/Greenland Research 250000 wire transf South America Education 25000 wire transf Cent. America/Caribbean Education 25000 wire transf Middle East/North Africa Education 100000 wire transf Russia Education 22258 wire transf Europe/Iceland/Greenland Education 100000 wire transf Middle East/North Africa Research 50000 wire transf South America Research 250000 wire transf Europe/Iceland/Greenland Research 175000 wire transf Europe/Iceland/Greenland Education 25000 wire transf North America Research 610000 wire transf East Asia/Pacific Research 585265 wire transf Sub-Saharan Africa Education 35000 wire transf Cent. America/Caribbean Education 134459 wire transf Europe/Iceland/Greenland Research 175000 wire transf Europe/Iceland/Greenland Education 34000 wire transf East Asia/Pacific Research 100000 wire transf East Asia/Pacific Research 180000 wire transf 30 0 false false false false false false Organization's Procedures for Monitoring Use of Grant Funds Outside the US Schedule F, Part V All research, education, screening, and treatment grantees are required to submit annual financial and progress reports and change requests for modifications to their project. All reports and requests are reviewed by science staff. See Schedule I, Part IV for more details. X X X X X true MERKLE INC DIRECT Marketing false 25518135 829811 24688324 25518135 829811 24688324 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY Gbl Race fr CUR 5845232 4284861 1560371 164799 3 Day Walk SE 82585768 79077928 3507840 2989860 2739590 7337597 2 2434468 1825851 608617 233484 238894 90865468 85188640 5676828 2989860 2973074 7741290 13704224 -8027396 Fundraising Events Schedule G, Part II Net Income Summary Gross Receipts are reduced by the amount of contributions per IRS instructions. The contributions for 2010 were $85,188,640. true Adventist Healthcare Inc 1801 Research Blvd Rockville MD 20853 521532556 501(c)(3) 917000 Research Albert Einstein College of Med at Yesh Univ 1300 Morris Park Avenue Bronx NY 10461 131624225 501(c)(3) 180000 Research American Association for Cancer Research 615 Chestnut St Philadelphia PA 19106 236251648 501(c)(3) 1070000 Education American Association on Health & Disability 110 N Washington St Rockville MD 20854 521884887 501(c)(3) 200000 Education American Jewish Joint 711 Third Avenue New York NY 100174014 131656634 501(c)(3) 261770 Education Arab Community Center for Economic and 6450 Maple Street Dearborn MI 48126 237444497 501(c)(3) 50000 Education Arlington Free Clinic 3833 N Fairfax Dr Arlington VA 22203 541671883 501(c)(3) 200000 Education Aultman Hospital 26210 Emery Rd Ste 307 Cleveland OH 44128 341445390 501(c)(3) 250000 Research Baylor College of Medicine One Baylor Plza BCM 206 Houston TX 77030 741613878 501(c)(3) 955000 Research Beth Israel Deaconess Medical Ctr Boston 330 Brookline Ave E/BR-259 Boston MA 02215 042103881 501(c)(3) 360000 Research Bioethics International 420 Lexington Avenue New York NY 10170 870774767 501(c)(3) 75000 Education Brigham & Women's Hospital Research Mgt Boston MA 022413149 042312909 501(c)(3) 250000 Research Burnham Institute 10901 N Torrey Pines Rd La Jolla CA 92037 510197108 501(c)(3) 450000 Research Cancer Care 275 Seventh Avenue New York NY 10001 131825919 501(c)(3) 250000 Treatment Cancer Legal Resource Foundation 919 Albany Street Los Angeles CA 90015 952960607 501(c)(3) 7500 Education Capital Breast Care Center 650 Pennsylvania Ave Washington DC 20003 530196603 501(c)(3) 200000 Education CASA of Maryland Inc 734 Univ Blvd E Silver Spring MD 20903 521372972 501(c)(3) 200000 Education C-Change 1776 I Street NW Washington DC 20006 161641769 501(c)(3) 50000 Education Center for Women Policy Studies 1776 Massachusetts Ave Washington DC 20036 520962100 501(c)(3) 10320 Education Children's Hospital Boston PO Box 414413 Boston MA 022414413 042774441 501(c)(3) 180000 Research Columbia University 630 West 168th Street New York NY 10032 133957095 501(c)(3) 448742 Research Columbia Univ College of Physicians & Surg 630 West 168th Street New York NY 10032 133957095 501(c)(3) 450000 Research Columbia University Medical Center 630 West 168th Street Attn Matthew Meyer New York NY 10032 135598093 501(c)(3) 300000 Research Trustees of Columbia Univ 630 W 168th St Box 49 New York NY 10032 133957095 501(c)(3) 250000 Research Commonweal PO Box 316 Bolinas CA 94924 942366094 501(c)(3) 181729 Education Conquer Cancer Foundation 2318 Mill Road STE 800 Alexandria VA 22314 311667995 501(c)(3) 250000 Education Cornell University Ithaca 341 Pine Tree Road Ithaca NY 14850 150532082 501(c)(3) 180000 Research Dana-Farber Cancer Institute 44 Binney Street BP333 Boston MA 02115 042263040 501(c)(3) 1655000 Research Delta State University CCED Post Office Box 3134 Attn Aurora Candelaria Cleveland MS 38733 646026565 501(c)(3) 20000 Education Duke University Medical Center 324 Blackweel St Ste 1000 Durham NC 27701 560532129 501(c)(3) 1590046 Research Research and Education Foundation 12935 S Gregory St 324 Blackweel Street Ste 1000 Blue Island IL 60406 363761674 501(c)(3) 218000 Research EO Lawrence Berkeley National Laboratory 1 Cyclotron Rd Berkeley CA 94720 942951741 501(c)(3) 250000 Research Facing Our Risk of Cancer Empowered 16057 Tampa Palms Blvd W Tampa FL 33647 650927702 501(c)(3) 50000 Education Fannie Lou Hamer Cancer Foundation 200 First Street SW 16057 Tampa Palms Blvd W 373 Ruleville MS 38771 861118042 501(c)(3) 20000 Education Fox Chase Cancer Center 333 Cottman Avenue 200 First Street SW Philadelphia PA 19111 232003072 501(c)(3) 450000 Research Fred Hutchinson Cancer Research Center 8750 N Mercer Wy Mercer Island WA 98040 237156071 501(c)(3) 1099999 Research Fred Hutchinson Cancer Research Center 8750 N Mercer Wy Mercer Island WA 98040 237156071 501(c)(3) 100000 Education Friends of Cancer Research 2231 Crystal Dr Arlington VA 22202 521983273 501(c)(3) 25000 Education Georgetown University Ourisman Health Ctr Lombardi Ground Fl Washington DC 20007 522218584 501(c)(3) 199990 Education Georgetown University Ourisman Health Ctr Lombardi Ground Fl Washington DC 20007 522218584 501(c)(3) 600000 Research Georgia Medical College of 1120 15th Street CJ-3301 Augusta GA 30912 741613878 501(c)(3) 600000 Research Harvard Medical School 1350 Massachusetts Av Cambridge MA 02138 042103580 501(c)(3) 180000 Research Harvard Medical School 1350 Massachusetts Av Cambridge MA 02138 042103580 501(c)(3) 231355 Education Henry Ford Health System One Ford Place 5E 1350 Massachusetts Avenue Detroit MI 48202 381357020 501(c)(3) 599850 Research Indiana University (Indianapolis) 620 Union Dr Rm 518 Indianapolis IN 46202 356001673 501(c)(3) 1237500 Research International Breast Cancer Research Fdn 660 John Nolan Drive 200 First Street SW Madison WI 53711 391766858 501(c)(3) 442783 Research International Scholarship & Tuition Serv 200 Crutchfield Ave at Yeshiva University Nashville TN 37210 621247492 501(c)(3) 160000 Education Johns Hopkins University 1101 E 33rd St Baltimore MD 21218 520595110 501(c)(3) 10000 Education Johns Hopkins University 1101 E 33rd St Baltimore MD 21218 520595110 501(c)(3) 1716853 Research Korean Community Svc Ctr of Greater WA 7700 Ltl Rvr Turnpike Annandale VA 22003 362167817 501(c)(3) 180000 Education Lankenau Institute for Medical Research 100 Lancaster Avenue Wynnewood PA 19096 232175659 501(c)(3) 599774 Research Lawrence Berkeley National Laboratory 1 Cyclotron Rd Berkeley CA 94720 942951741 501(c)(3) 177988 Research Living Beyond Breast Cancer 354 W Lancaster Av Haverford PA 19041 232734689 501(c)(3) 200000 Education MD Anderson Cancer Center Univ of Texas Grants Contracts 354 West Lancaster Avenue Houston TX 772104390 746001118 501(c)(3) 120000 Research Maasai Wildernes Conservation Fund 497 Scaife Hall Santa Barbara CA 93102 660627488 501(c)(3) 50000 Education Mary's Ctr for Maternal&Child Care Inc 2333 Ontario Road NW Washington DC 20009 521594116 501(c)(3) 200000 Education Massachusetts General Hospital 32 Fruit St Yawkey 8C Boston MA 021142554 042697983 501(c)(3) 400000 Research Mayo Clinic and Foundation Jacksonville 4500 San Pablo Road 32 Fruit Street Yawkey 8 C Jacksonville FL 32224 416011702 501(c)(3) 597940 Research Mayo Clinic and Foundation Rochester 200 First Street SW 4500 San Pablo Road Rochester MN 55905 416011702 501(c)(3) 1050000 Research Medical College 8701 Watertown Plk Rd Milwaukee WI 53226 390806261 501(c)(3) 250000 Research Memorial Sloan-Kettering Cancer Ctr 1275 York Ave New York NY 10021 131924236 501(c)(3) 1270000 Research Mercy Health Foundation 301 St Paul Place 1275 York Avenue Baltimore MD 21202 522173656 501(c)(3) 15000 Screening Mercy Health Foundation 301 St Paul Place HH 102 - Epidem Preventive Baltimore MD 21202 522173656 501(c)(3) 1048493 Research Metropolitan Chicago Breast Cancer 1645 W Jackson Blvd Chicago IL 606123244 262264895 501(c)(3) 600000 Screening Michigan State University 301 Admin Building East Lansing MI 48824 386005984 501(c)(3) 450000 Research Mississippi State Department of Health 570 E Woodrow Wilson Jackson MS 39215 566001393 501(c)(3) 60000 Education Mount Sinai School of Medicine New York 1 Gustave L Levy Pl New York NY 100296574 136171197 501(c)(3) 780000 Research National Academy of Sciences 730 15th Street NW One Gustave L Levy Place Washington DC 20005 530196932 501(c)(3) 1000402 Research National Association of Chronic Disease 2872 Woodcock Blvd B-030 Graves Hall Atlanta GA 30341 731328414 501(c)(3) 25000 Screening New York University School of Medicine 550 First Avenue Suite 220 New York NY 100166481 135562308 501(c)(3) 550000 Research North Colorado Medical Center 2001 70th Avenue GBH-SC1-47 Greeley CO 80634 840718355 501(c)(3) 20169 Screening Northwestern University 750 N Lake Shore Dr Chicago IL 60611 362167817 501(c)(3) 180000 Research Northwestern University Feinberg School 750 N Lake Shore Dr Chicago IL 60611 362167817 501(c)(3) 180000 Research NSABP Foundation Inc 201 N Craig St Pittsburgh PA 15213 251781357 501(c)(3) 25000 Research Nueva Vida Inc 2000 P St NW Washington DC 20036 541943145 501(c)(3) 200000 Education Patient Advocate Foundation 700 Thimble Shoals Newport News VA 23606 541806317 501(c)(3) 250000 Education Patient Advocate Foundation 700 Thimble Shoals Newport News VA 23606 541806317 501(c)(3) 1750000 Treatment Prevent Cancer Foundation 1600 Duke Street Suite 200 Alexandria VA 22314 521429544 501(c)(3) 199925 Education Prince George's County Health Dept 1801 McCormick Dr Ste 260 Largo MD 20774 522046026 501(c)(3) 200000 Education Princeton University 5 New South Building Princeton NJ 08544 210634501 501(c)(3) 768750 Research Providence Health Foundation 1150 Varnum Street NE 5 New South Building Washington DC 20017 521275583 501(c)(3) 1000000 Screening Providence Portland Medical Center 4805 NE Glisan St Portland OR 972132933 931231494 501(c)(3) 449888 Research Purdue University 302 Wood St West Lafayette IN 479072108 356002041 501(c)(3) 180000 Research Quantum Leap HealthCare Collaborative 320 Fairway Drive Half Moon Bay CA 94019 204284925 501(c)(3) 38000 Education ReaganUdall Foundation 800 I Street NW Washington DC 20001 263727917 501(c)(3) 100000 Education Research Advocacy Network 6505 West Park Boulevard 800 I Street NW Plano TX 75093 352209499 501(c)(3) 50000 Education Rush University 1700 West Van Buren Suite 305 PMB 220 Chicago IL 60612 362174823 501(c)(3) 450000 Research Sir Mortimer B Davis - Jewish General Hospital L 4777 E Galbraith Rd Cincinnati OH 45236 986001162 501(c)(3) 449982 Research Society of Surgical Oncology 85 W Algonquin Rd Arlington Hts IL 60005 136161070 501(c)(3) 115000 Research Society of Surgical Oncology 85 W Algonquin Rd Arlington Hts IL 60005 136161070 501(c)(3) 20000 Education Stanford University PO Box 44253 San Francisco CA 941444253 941156365 501(c)(3) 718225 Research Temple University 1938 Liacouras Wk Philadelphia PA 19122 231365971 501(c)(3) 450000 Research The Mautner Project 1875 Connecticut Av Washington DC 20009 521703915 501(c)(3) 200000 Education The Salk Institute 10010 N Torrey Pines Rd La Jolla CA 92037 956136024 501(c)(3) 250000 Research The University of Chicago 970 East 58th St Chicago IL 60637 362177139 501(c)(3) 250000 Research Thomas Jefferson University 1020 Walnut St Philadelphia PA 19107 231352651 501(c)(3) 600000 Research Trustees of Boston University BUMC 580 Harrison Avenue 3-W Boston MA 02118 042103547 501(c)(3) 178191 Research Tulane University Health Sciences Center 6823 St Charles Ave New Orleans LA 70119 720423889 501(c)(3) 180000 Research Univ of North Carolina at Chapel Hill 104 Airport Dr 155 Whitney Ave Room 230 Chapel Hill NC 275991350 566001393 501(c)(3) 425000 Research Univ of Texas MD Anderson Cancer Center PO Box 4390 Houston TX 772104390 746001118 501(c)(3) 562500 Research University of Alabama at Birmingham 1530 3rd Ave S Birmingham AL 35294 630649108 501(c)(3) 1030000 Research University of California at Irvine 1655 Grant St Bldg A Concord CA 94520 952226406 501(c)(3) 600000 Research University of California at Los Angeles 10920 Wilshire Blvd Los Angeles CA 90024 952250801 501(c)(3) 630000 Research University of California at San Diego UCSD Cashiers Offc La Jolla CA 920930009 956006144 501(c)(3) 540000 Research University of California at San Francisco 1855 Folsom Street San Francisco CA 94143 946036493 501(c)(3) 7384270 Research University of California at Santa Cruz 1156 High Street Santa Cruz CA 95064 941539563 501(c)(3) 180000 Research University of California Helen Diller FCCC 1855 Folsom St San Francisco CA 94143 946036493 501(c)(3) 180000 Research University of California-Davis One Shield Ave Davis CA 95616 946036494 501(c)(3) 450000 Research University of California-Los Angeles 10920 Wilshire Blvd Los Angeles CA 90024 956006143 501(c)(3) 250000 Research University of California-San Francisco 1855 Folsom Street San Francisco CA 94143 946036493 501(c)(3) 680000 Research University of Cincinnati 51 Goodman Dr Cincinnati OH 45221 316000989 501(c)(3) 450000 Research University of Colorado at Denver Fitzsimons Campus PO Box 210222 Denver CO 802910238 856000555 501(c)(3) 180000 Research University of Colorado Health Sciences Ctr 500 Fitzsimons Bldg Aurora CO 80045 846000555 501(c)(3) 120000 Research University of Illinois at Chicago 809 S Marshfield Ave Chicago IL 60612 376000511 501(c)(3) 403119 Research University of Kansas Medical Center 3901 Rainbow Blvd Kansas City KS 66160 481108830 501(c)(3) 62500 Research University of Miami School of Medicine Offc of Exp Compl Miami FL 33136 590624458 501(c)(3) 1199997 Research University of Michigan 3003 S State St Ann Arbor MI 481091287 386006309 501(c)(3) 2100000 Research University of Minnesota at Twin Cities 200 Oak St SE Minneapolis MN 55455 416007513 501(c)(3) 1029975 Research University of Nebraska 987835 Nebraska Omaha NE 68198 470049123 501(c)(3) 180000 Research University of Oklahoma Health Sciences Center 1000 Stanton Yng Blvd Oklahoma OK 73117 736017987 501(c)(3) 599966 Research University of Pennsylvania School of Medicine 3451 Walnut St Philadelphia PA 19104 231352685 501(c)(3) 1380000 Research University of Pittsburgh Cancer Institute 497 Scaife Hall Pittsburgh PA 15251 250965591 501(c)(3) 626610 Research University of Portland 726 NW 11th Avenue 508 PO Box 371220 Portland OR 97209 930401259 501(c)(3) 50000 Education University of Texas at Houston 7000 Fannin Street 726 NW 11th Avenue 508 Houston TX 77030 741587488 501(c)(3) 269722 Research University of Texas at Southwestern Medical Center 5323 Harry Hines Blvd 7000 Fannin Street Dallas TX 75390 756002868 501(c)(3) 180000 Research University of Texas Health Science Center at San A 501 W Durango 1515 Holcombe Boulevard San Antonio TX 78207 741586031 501(c)(3) 600000 Research University of Texas MDAnderson Cancer Center 1515 Holcombe Blvd Houston TX 77030 741586031 501(c)(3) 180000 Research University of Utah 201 Presidents Cir Salt Lake city UT 84112 876000525 501(c)(3) 180000 Research University of Washington 12455 Collections Drive 411 Chicago IL 60693 916001537 501(c)(3) 500000 Research University of Wisconsin at Madison 1440 Monroe Street 12455 Collections Drive Madison WI 53711 396006492 501(c)(3) 447705 Research University of Wisconsin School of Medicine and Pub 21 North Park St Madison WI 53711 396006492 501(c)(3) 450000 Research UT Health Science Center at San Antonio 7703 Floyd Curl Drive Grants Contracts San Antonio TX 78229 741586031 501(c)(3) 250000 Research UTMD Anderson Cancer Ctr 1515 Holcombe Boulevard 7703 Floyd Curl Drive Houston TX 77030 746001118 501(c)(3) 800000 Research Vanderbilt University Medical Center 3319 West End Av Nashville TN 37203 620476822 501(c)(3) 250000 Research Vasculitis Foundation PO BOX 28600 Kansas City MO 64188 431492959 501(c)(3) 7000 Research Vietnamese Resettlement Association Inc 6131 Willston Dr Falls Church VA 22044 541512549 501(c)(3) 200000 Education Wake Forest University Health Sciences Medical Ctr Blvd WinstonSalem NC 27157 223849199 501(c)(3) 600000 Research Washington Cancer Institute 110 Irving St NW Washington DC 20010 521791670 501(c)(3) 200000 Education Washington University at St Louis School of Medi Campus Box 1034 Building 31 Room 11A-48 St Louis MO 631121408 430653611 501(c)(3) 7280000 Research Washington University at St Louis School of Medi Campus Box 1034 Building 31 Room 11A-48 St Louis MO 631121408 430653611 501(c)(3) 750000 Screening West Virginia University 3120 University Avenue Campus Box 1034 Morgantown WV 26505 550665758 501(c)(3) 450000 Research Whitehead Institute for Biomedical Research 9 Cambridge Center 3120 University Avenue Cambridge MA 021421479 061043412 501(c)(3) 600000 Research Wistar Institute 3601 Spruce St Philadelphia PA 19104 236434390 501(c)(3) 599999 Research Women Deliver 588 Broadway 85 W Algonquin Road New York NY 10012 264462256 501(c)(3) 15000 Education Yale University 155 Whitney Ave New Haven CT 06520 060646973 501(c)(3) 270000 Research General Hospital Corp 50 Staniford St Boston MA 02114 362177139 501(c)(3) 250000 Research 126 0 Form 990, Schedule I Description of Organization's Procedures for Monitoring the Use of Grants Susan G. Komen for the Cure's (the Organization) policies for managing research grants from the time of initial award through completion seek to maximize flexibility while maintaining the highest standard of accountability and preserving the integrity of the review and funding process. Throughout the term of the grant, scientific progress is monitored by a Science Manager assigned to the grant. Grantee is required to submit annual scientific progress reports that must include the following: Hypothesis and Specific Aims: Progress on each specific aim in the research plan, including a description of progress, justification for delays or changes, the projected completion date for research addressing the specific aim, and current status. Justification and approval is required prior to implementation of any changes to the research design or specific aims. Research Outcomes: A list of the research accomplishments during the reporting period. Publications, Presentations & Posters: A list of all manuscripts submitted, in press, or published, with full citation information and a list of all posters displayed or presentations delivered at scientific meetings. Patents, Products, Copyrights & Intellectual Property: A list of all patents or patent applications filed during the reporting period and a list of specific research products developed during the reporting period. Examples of products include novel therapeutic targets, biomarkers, vectors, novel therapies, risk assessment tools and/or algorithms, new technologies, educational materials, etc. Professional Awards & Promotions: A list of all professional awards and promotions received by any of the key personnel. An annual scientific progress report is due on each anniversary of the grant start date for the duration of the project, except for the final year of the grant when a final report is due no later than 30 days after the end date of the grant term. Final scientific progress reports include the information requested above as well as: Research Conclusions: A brief narrative followed by a bulleted or numbered list of the key outcomes, research accomplishment and conclusions drawn at the end of the research project, and a brief description of the future prospects and/or next steps in the line of inquiry investigated during the grant term. An annual scientific progress report also is due if the Grantee is requesting an extension to the end of the grant term or acceleration of the Grant term. With reasonable prior notice to Grantee, the Organization may require additional reporting from Grantee and also may require Grantee to participate in site visits, telephone conferences, presentations or other speaking engagements. Annual financial reports are due no later than 30 days after each anniversary of the Grant start date for the duration of the grant term, with the exception of the final financial report, which is due no later than 60 days after the end date of the Grant term. Any unexpended funds must be remitted with the final financial report to the Organization, unless otherwise directed by the Organization. The Organization's policies for managing community grants and other non-research related grants from the time of initial award through completion seek to maximize flexibility while maintaining the highest standard of accountability and preserving the integrity of the review and funding process. All grantees must sign a grant contract which sets forth the terms of the grant, including the purpose of the grant, amount, budgetary restrictions, duration payment schedule, reporting requirements, and audit and early termination rights for the Organization. The grantee is required to submit progress reports (typically every six months) that detail progress towards meeting each of the objectives and any challenges encountered. The report must also include a full accounting of grant funds awarded (actual versus budgeted expenses). The Program Manager may conduct site visits with a grantee when appropriate to build a stronger relationship with the grantee; to gain a better understanding of its work; and to address any challenges or problems the grantee is facing. Any changes to the project must be approved by the Organization's Program Manager in writing in advance of the change. A final report must be provided within 45 days after the completion or early termination of the grant and must include evaluation of the program's accomplishments and impact in the community. Any unexpended funds must be remitted with the final report and final financial report to the Organization unless otherwise directed by the Organization. X true true X X X X X true false false false false true false false false Nancy G Brinker 411254 0 400 0 5517 0 0 0 541 0 417712 0 0 0 Elizabeth Thompson 214385 0 400 0 2135 0 9951 0 6226 0 233097 0 0 0 Katrina McGhee 213921 0 400 0 2072 0 10025 0 2179 0 228597 0 0 0 Mark Nadolny 275676 0 400 0 1560 0 7554 0 9726 0 294916 0 0 0 Jonathan Blum 207842 0 400 0 2027 0 10102 0 12022 0 232393 0 0 0 Justin Ricketts 207126 0 400 0 2015 0 12794 0 4419 0 226754 0 0 0 Emily Callahan 152013 0 0 0 1477 0 8409 0 569 0 162468 0 0 0 Marianna Alciati 166728 0 0 0 26843 0 9821 0 4839 0 208231 0 0 0 Nancy MacGregor 149782 0 400 0 3159 0 9502 0 6622 0 169465 0 0 0 Diana Rowden 164484 0 425 0 3262 0 10068 0 1920 0 180159 0 0 0 Susan Carter-Johns 161804 0 400 0 2802 0 10411 0 9726 0 185143 0 0 0 Eric Winer 177497 0 400 0 0 0 0 0 0 0 177897 0 0 0 Julie C Teer 196382 0 400 0 1955 0 0 0 0 0 198737 0 0 0 Mona L Locke 164793 0 421 0 2159 0 0 0 2233 0 169606 0 0 0 David A Dawson 160717 0 530 0 1918 0 9120 0 6226 0 178511 0 0 0 Lesley Lurie 158224 0 400 0 1560 0 9792 0 3019 0 172995 0 0 0 Samuel Cheng 156621 0 400 0 2108 0 9156 0 0 0 168285 0 0 0 Hala Moddelmog 0 0 0 0 277864 0 0 0 1870 0 279734 0 0 0 Kimberly Earle 35878 0 0 0 233731 0 2164 0 8 0 271781 0 0 0 Annetta Hewko 0 0 0 0 134483 0 0 0 0 0 134483 0 0 0 Supplemental Compensation Information Schedule J, Part III First class and business class fares for domestic travel, Canada, the Caribbean, Central America, and Mexico are not reimbursable. However, personal frequent flier mileage and/or coupons may be used for no-cost upgrades. Only the CEO and Founder are approved for first class travel. Whenever possible discounted first class and upgrades are used to minimize cost. Schedule J, Part I, Line 4A Severance payments were made to the following during calendar year 2010: Annette Hewko, Kimberly Earle, Hala Moddelmog, and Marianna Alciati. Schedule J, Part I, Line 6A The SMARTpay Incentive Plan is designed to drive organizational performance, enhance the organizations competitive pay position and positively affect our ability to attract and retain talent. Currently, annual operational financial performance at Headquarters must provide full funding of the board approved budgeted slate of research grants and mission activity while ensuring adjusted net operating activity remains at breakeven. This SMARTpay Incentive Plan is an annual program, giving full discretion to the organizations Board of Directors for renewal, suspension, or termination of the plan. The SmartPay Incentive plan is available to all employees of the Parent. No amounts were paid for calendar year 2010. Schedule J, Part J-2 Jennifer Luray was an officer of the Susan G. Komen Breast Cancer Foundation, Inc. 100% of her compensation is being reported on Susan G. Komen for the Cure Advocacy Alliance's form 990, Part VII and Schedule J. X 2 38786 cost or sale price X 2 9380 cost or sale price false true false Volunteers Form 990, Part I, Question 6 Volunteers serve in a variety of ways but the greatest number of volunteers assist with the Breast Cancer 3 Day series. Program Service Accomplishments Part III Nancy G. Brinker promised her dying sister, Susan G. Komen, that she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure (Komen) and launched the global breast cancer movement. Today, Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure, Komen has invested nearly $2 billion to fulfill its promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world. A - Research and Training Komen has touched virtually every major advance in breast cancer research over the past 30 years. By funding the best scientists around the world, Komen is speeding the translation of research discoveries to reduce breast cancer incidence and mortality within the next decade. To ensure maximum impact for its research dollars, Komen for the Cure is guided by a Scientific Advisory Board, a group of internationally recognized doctors, scientists and advocates, and the consultation of the Komen Scholars, almost 70 scientists and advocates. Komen made 183 grants in fiscal year 2011 through the granting programs, described below, to support research and training in 26 US states and other countries including Australia, Belgium, Canada, England, Israel, Italy, and Switzerland. Komen supports research and training through several different types of grants, each designed to meet specific objectives. The following grant opportunities were offered by Komen during fiscal year 2011: - Promise Grants: Large-scale grants, up to $6.5 million each, during a five-year period, targeted to research that brings science to the bedside quicker than ever before. - Post-Doctoral Fellowships: Grants of $60,000 per year for two or three years to attract and retain promising young researchers. - Career Catalyst Research: Grants of $150,000 per year for two to three years to fill a critical gap in support and stimulate the transition from training to independence among promising cancer investigators. - Investigator Initiated Research: Grants of up to $200,000 per year for two to three years to explore new ideas and approaches with significant potential to lead to reductions in breast cancer mortality and/or incidence within the decade. - Post Baccalaureate in Disparities Research: Grants up to $135,000 per year over three years to support training programs for graduate students in the area of breast cancer disparities. Approximately 40% of these grants are exploring the biology of breast cancer, including how cancer starts, grows and spreads. The next largest group of grants (20%) is for research on new and improved ways to detect cancer earlier. Almost 15% are supporting research into new breast cancer treatments, with several focusing on especially aggressive forms of the disease such as triple negative breast cancer. Another 15% of the grants are specifically looking for ways to prevent breast cancer. Below are three examples of promising research grants funded in fiscal year 2011: Researchers at Washington University School of Medicine in St. Louis are working to develop personalized breast cancer DNA vaccines, targeting unique tumor antigens identified by sequencing patients' genomes (DNA). The vaccines are being tested as a way to prevent breast cancer recurrence, but in the future may be given in conjunction with chemotherapy and radiation, or even in place of those treatments. A personalized cancer vaccine strategy is potentially applicable to all breast cancer patients, regardless of the subtype (e.g., triple negative, ER+, HER2+), and likely could be applied to other types of cancer as well. University of Michigan researchers have teamed up to develop novel therapies for triple negative breast cancer (TNBC) by targeting cancer stem cells (CSCs), which are resistant to radiation and chemotherapy and are highly invasive. Cancer stems cells are more abundant in TNBC and may also be more frequent in Black African and African-American women, which may account for the aggressive nature of TNBC and contribute to racial disparities in outcomes. About 5% to 10% of breast cancer cases are thought to be hereditary, resulting directly from gene defects (mutations) inherited from a parent. The known mutations are very rare in the population, but their effect on breast cancer risk is very strong. A research team at New York University is working to discover these genetic mutations, leading to more reliable identification of individuals at high-risk for breast cancer, and better therapies targeted against the mutations. Komen also supported dozens of partnerships and special projects to advance research and our understanding of breast cancer around the world. These grants respond to unique opportunities, leverage the work of different organizations, and address critical challenges and cross-cutting issues in research, clinical practice, and public health. Examples of special research efforts committed in fiscal year 2011 include the following: American Association for Cancer Research (AACR) - Komen has partnered with AACR to bring a variety of programming to the breast cancer research community, including researchers and advocates. In fiscal year 2011 alone, Komen awarded $1M to the AACR in support of five major scientific conferences - on topics ranging from molecular diagnostics to the science of health disparities -- and for the Scientist-Survivor Program. Workshop on Systems Toxicology Analysis of Targeted Anti-Cancer Therapies - The Reagan-Udall Foundation for the FDA and Friends of Cancer Research convened experts from academia, government, and industry to study the cardio-toxic effects of a class of anti-cancer drugs called tyrosine kinase inhibitors (TKIs). The goal is to use this knowledge about the signaling pathways leading to these side effects to develop biomarkers that could help identify patients with favorable risk/benefit profiles, or consider approaches to prevention of toxicity. The Institute of Medicine (IOM) Breast Cancer and the Environment Project - With widely divergent opinions within the scientific community on the role of chemicals, the environment and lifestyle in cancer development, Komen is working with the IOM for a second year to review and assess the strength of the science regarding possible links between breast cancer and the environment. The IOM will publish its findings and recommendations in a technical report and accompanying lay summary. B - Education Komen is a trusted source of breast health and breast cancer information for people all over the world and is instrumental in connecting people with the resources they need in their fight against breast cancer. Our award-winning website, www.komen.org, provides safe, accurate, comprehensive, and unbiased information about breast cancer based upon scientific evidence, as well as information about our research programs, community programs, volunteer opportunities, and events. The "Understanding Breast Cancer" section of the website, co-developed with Harvard Medical School, received over 2.4 million visits during fiscal year 2011. Komen also produces science-based, easy-to-read educational materials. Nearly 6.5 million educational materials were distributed in fiscal year 2011. Examples of Komen educational materials include the following: - Breast Self-Awareness cards in 18 languages for 20 specific audiences - General breast health awareness and breast cancer specific brochures and fact sheets - Booklets with support information for survivors and co-survivors Komen's trained and caring breast care helpline staff (1-877 GO KOMEN) provide answers to questions, local resources and moral support. Last fiscal year, the Susan G. Komen for the Cure breast cancer helpline responded to nearly 14,000 calls. While African American women are less likely to be diagnosed with breast cancer than Caucasian women, they are more likely to die from the disease. Susan G. Komen for the Cure Circle of Promise further engages African American women, and black women around the world, in the fight against breast cancer. At the end of fiscal year 2011, a total of 100,000 ambassadors had been recruited to do the following: - Mobilize the community to ensure that women everywhere have access to the care they need - Empower women to make a promise to reclaim their lives, their health and to be strong advocates in their communities - Dispel myths in the African American community that prevent women from getting early treatment for breast cancer Program Service Accomplishments Continued Part III I AM THE CURE is an educational program that teaches simple, action-oriented, breast health information to participants in the Susan G. Komen Race for the Cure series. Last year, nearly 1.7 million people participated in a Race for the Cure event. A formal evaluation showed that 82% of participants recalled the message that early detection is key to survival. The mobile community education and outreach tour, Komen On the Go, shares important information about breast cancer with all generations. This nationwide initiative is a fun, hands-on learning experience that engages people at community locations such as health fairs, shopping malls, churches, colleges and university campuses. Last year, the Komen On the Go vehicles were in more than 40 communities and reached 30,000 people with educational messages. Cancer kills more people, worldwide, than TB, HIV/AIDS and Malaria combined. Komen is waging the global fight against breast cancer by building and strengthening grassroots programs through networking, training, capacity building and financial support. In fiscal year 2011, 244 breast cancer advocates in six countries (Brazil, Egypt, Mexico, Panama, Romania, and Ukraine) were trained through the Course for the Cure, which is the cornerstone of the Komen's Global Initiative for Breast Cancer Awareness. Course for the Cure is a series of easily adaptable training modules that are based on Komen's best practices and experience in breast cancer awareness and advocacy. Additionally, Komen awarded grants for outreach programs in Bosnia and Herzegovina, Colombia, Costa Rica, Egypt, Ghana, Hungary, Israel, Kenya, Montenegro, Panama, Romania, Russia, and Ukraine and conferences in Brazil and Egypt. C - Screening Getting regular screening tests is the best way for women to lower their risk of dying from breast cancer. Screening tests can find breast cancer early, when it's most treatable. Komen supports free and low-cost mammogram programs in communities for women without health insurance or those with high co-pays and deductibles that make getting a mammogram too costly. D - Treatment Countless numbers of patients delay or forgo breast cancer treatment each year and as a result, these women are less likely to survive. For this reason, Komen supports programs that connect people with local resources, provide emergency financial assistance, and help coordinate care. Komen also supports two national patient assistance programs. One grant was awarded to the national cancer support organization, CancerCare, to support the Linking A.R.M.S. program. The program provides direct financial assistance to approximately 1,200 women for treatment-related expenses for including pain and anti-nausea medication, lymphedema care, oral chemotherapy, and durable medical equipment. CancerCare also provides counseling and other support services that enable breast cancer patients to make informed treatment decisions, cope with the emotional effects of the disease, and experience an improved quality of life. In addition, Komen made a $2 million grant to the Patient Advocate Foundation, a national non-profit organization that handles medical debt crisis management. The grant will provide pharmaceutical co-payment help to more than 850 breast cancer patients nationwide and will also allow PAF to directly reach out to African American and Hispanic/Latina breast cancer patients, increasing awareness about resources available to them. All told, Komen has committed more than $1.3 billion to community programs since 1982, and in FY 2011 partnered with almost 2,000 organizations to provide education, screening, treatment support and psychosocial programs. For more information about any of the accomplishments described here or to learn more about Susan G. Komen for the Cure, visit www.komen.org or call 1-877 GO KOMEN. Description of Relationships Form 990, Part VI, Question 2 Eric Brinker, Board Member, is the son of Nancy G. Brinker, CEO and Board member. Describe the Process used by Management &/or Governing Body to Review 990 Form 990, Part VI, Question 11b Management prepares the materials for the Form 990, with the assistance and review by external accountants. Senior levels of management review and comment on the final draft of the Form 990 for presentation to the audit committee of the board of directors. The audit committee of the Board of the Directors reviews and approves the Form 990 prior to being filed. Thereafter, each member of the Board of Directors receives an electronic copy of the Form 990 via email prior to the form being filed. Description of Process to Monitor Transactions for Conflicts of Interest Form 990, Part VI, Question 12c The organization produces an annual survey requiring all employees, board members, committee members and advisory boards to inform on conflicts. Any conflicts are then reviewed by management and the audit committee and appropriate measures are taken. In addition, those same people have the obligation to update the conflict of interest statements during the year. Offices & Positions for Which Process was Used, & Year Process was Begun Form 990, Part VI, Question 15a and 15b The Compensation Committee of the Board of Directors assists the Board of Susan G. Komen for the Cure in overseeing compensation policies and practices. Responsibilities include oversight of the compensation of the President/ Chief Executive Officer, the range of compensation levels for the organizations other officers, disqualified persons, and other employees, granting the CEO authority to determine actual compensation levels within an approved range, and incentive/bonus compensation programs. The current policy was adopted in 2010. A formal Compensation Policy governs pay practices. Periodically, all positions in the organization are reviewed against external market data, engaging independent experts to conduct the benchmarking process. Compensation is then based upon comparable market rates of pay with consideration for internal equity and the financial position of the organization. The process was last conducted this fiscal year. Salary increases, promotions or other forms of compensation are provided without regard to race, color, religion, gender, national origin, disability, veteran status or sexual orientation. Avail of Gov Docs, Conflict of Interest Policy, & Fin Stmts to Gen Public Form 990, Part VI, Question 19 The Organizations financial statements, conflict of interest policy and the 990 are publicly available on our website. The Articles of Incorporation are available from the Texas Secretary of State and other governing documents are made available as required by state law. Form 1023 is not online but available to the public upon request. ADDITIONAL DETAIL ON RACE PRODUCTION EXPENSES INCLUDED ON OTHER EXP LINE Form 990, Part IX, Line 24 THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. PURCHASES ALL T-SHIRTS FOR THE 100 PLUS RACES HELD BY THE KOMEN AFFILIATES DURING THE YEAR. Other changes in Net Assets Part XI Reconciliation of Net Assets Unrealized gains on investments = $11,234,103 In Kind services Revenues = $20,645,021 In Kind services expenses =($21,593,231) Rescinded Grants = $954,975 Rounding = ($4) ------------- Total $11,240,864